JUNS
Jupiter Neurosciences, Inc. Common Stock
NASDAQ: JUNS · HEALTHCARE · BIOTECHNOLOGY
$0.38
+5.33% today
Updated 2026-04-30
Market cap
$13.16M
P/E ratio
—
P/S ratio
603.58x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
0.1M
Jupiter Neurosciences, Inc. Common Stock (JUNS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-12,887.00%
ROE
-739.00%
ROA
-94.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-3.05M | — | — | — |
| 2020 | $1.13M | $-1.65M | 100.00% | -164.41% | -146.92% |
| 2021 | $638037.00 | $-4.38M | 100.00% | -612.36% | -686.39% |
| 2022 | $233281.00 | $-4.96M | 100.00% | -1,471.38% | -2,125.15% |
| 2023 | $0.00 | $-4.78M | — | — | — |
| 2024 | $0.00 | $-2.44M | — | — | — |
| 2025 | $21796.00 | $-8.64M | 80.59% | -40,873.19% | -39,662.77% |